Home
Conditions
Blood Protein Disorders

Clinical trial condition

Blood Protein Disorders

Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.

3,034 public trials 567 recruiting studies

Refine in advanced search Browse all conditions

Blood Protein Disorders trial results

Active, Not Recruiting

Selinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin Lymphoma

NCT03147885

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Diffuse Large B-cell Lymphoma, +35 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Active, Not Recruiting

Nivolumab and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma

NCT03015896

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +42 more
Locations: Emory University Atlanta, Georgia, United States

Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Active, Not Recruiting

Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study

NCT04537871

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +32 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, Not Recruiting

I-FALMIN Albumin Supplement for Patients With Pulmonary Tuberculosis

NCT07186478

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +14 more
Locations: RSUD Wahidin Sudirohusodo Makassar, South Sulawesi, Indonesia

View Trial Details

Active, Not Recruiting

A Study of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple Myeloma

NCT06381141

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations: Mayo Clinic Phoenix, Arizona, United States

Mayo Clinic Jacksonville, Florida, United States

Mayo Clinic Rochester, Minnesota, United States

Mt. Sinai New York, United States

View Trial Details

Active, Not Recruiting

Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients

NCT05823571

Conditions: Blood Protein Disorders, Bone Marrow Diseases, CML, +34 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Active, Not Recruiting

Study of ATLCAR.CD138 Cells for Relapsed/Refractory Multiple Myeloma

NCT03672318

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill, North Carolina, United States

View Trial Details

Active, Not Recruiting

S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration

NCT04071457

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States

Anchorage Radiation Therapy Center Anchorage, Alaska, United States

Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States

Alaska Oncology and Hematology LLC Anchorage, Alaska, United States

View all 842 locations

View Trial Details

Active, Not Recruiting

Integrated Actionable Aging Assessment for Cancer Patients Pilot

NCT05871008

Conditions: Bladder Cancer, Blood Protein Disorders, Breast Cancer, +49 more
Locations: University of Colorado Hospital Aurora, Colorado, United States

View Trial Details

Active, Not Recruiting

A Study of Health-Related Quality of Life in People With Multiple Myeloma Receiving Daratumumab or Lenalidomide

NCT04497961

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States

Memorial Sloan Kettering Commack (Limited protocol activities) Commack, New York, United States

View Trial Details

Blood Protein Disorders

Blood Protein Disorders trial results

Related conditions